See the Glossary for more terms.
As the end of the fiscal year approaches, we enter a new phase for funding applications.
All FY 2011 applications that scored within a payline are either committed for funding or funded, so the paylines are not relevant and we’ve removed them from our Web site.
We are now awarding some higher-scoring applications, including selective pay and others that missed the payline. If your application scored above the payline and you're waiting to hear about a funding decision, you should hear soon.
We are able to fund these applications because earlier in the fiscal year we set conservative paylines to make sure we have enough money to pay all the high-quality grants that may come in throughout the fiscal year. As a result, we have money left over to pay some additional grants.
On September 1, we will announce an interim R01 payline for FY 2012 on NIAID Paylines. Note that an interim payline is an administrative action that enables us to fund very low-scoring (high-quality) applications while we do not have a budget. Because interim paylines are not true paylines, we do not announce them through our Email Alerts.
For more information, read the pages listed below.
If you have a fundable application with a bar to award due to study section concerns about human subjects or animal research, NIAID is issuing restricted awards that prevent you from spending some (or maybe all) of your money until NIH lifts the bar—a process that can take months.
For those who have already received restricted awards, send your documentation quickly to ensure your application gets to the front of the bar-lifting line. NIH processes requests on a first-come, first-served basis.
Once we get the go-ahead to finish processing your award, we issue a revised Notice of Award ASAP so you can conduct all of your research. Get details in the Bars to Grant Awards—Human Subjects and Bars to Grant Awards—Research Animals SOPs.
For more information, read previous NIAID Funding Newsletter articles:
Since time is of the essence, you may also want to read our advice on connecting with NIAID staff:
Time is on your side if you're interested in the following funding opportunities: Research to Advance Vaccine Safety (R01) and Research to Advance Vaccine Safety (R21).
Both were set to expire next month, but thanks to a recent change, won't close until January 8, 2012. See the July 28, 2011, Guide notice for the official word.
Get a leg up in reaching your commercialization goals with NIH's Commercialization Assistance Program (CAP). The application deadline is September 1, 2011, so you better hurry if you're interested in participating.
CAP helps you develop a solid market-entry plan and evaluate your commercialization options based on your specific technologies. You'll also benefit from:
The program may prove priceless for your business, but it's free if yours is among the 40 companies picked to participate.
You are eligible if your SBIR phase II award is active or was active in the past five years. If you're selected, you will start the program in October and end in June 2012.
Find details and application instructions at Commercialization Assistance Program (CAP) for Phase II SBIR Awardees.
In case you missed it, NIH issued a Guide notice last month on what you can put in the Appendix of NRSA Institutional Research Training Grant (T32) and Short-Term Institutional Research Training Grant (T35) applications.
Items that are allowed include publications, course syllabi, recruitment materials, and forms to track trainee progress. Find complete details in the July 28, 2011, Guide notice and the supplemental instructions for Ts in the SF 424 Application Guide.
Here are some other items of note.
Enhancing Human Subjects Rules. Give your input on potential changes to regulations governing ethics, safety, and oversight of human subjects research. Find FAQs, instructions on how to submit feedback, and other resources at HHS's ANPRM for Revision to Common Rule. Comments are due September 26, 2011.
NIH's Genetic Testing Registry: Comments Please. Weigh in on several issues related to the Genetic Testing Registry, including whether the information it proposes to collect has practical benefit. Send feedback by September 26, 2011, and read more in the July 27, 2011, Federal Register notice.
You're probably already familiar with the alphabetical way to navigate the most popular resources and links on the Research Funding site: the Find It! A-Z list. NIAID also offers indexes for our Standard Operating Procedures, Questions and Answers, and portals on Grants topics.
But sometimes, knowing the navigation isn't efficient enough. You can save time using a well-chosen search—not just for the Research Funding site but anywhere online.
Search the Page You're On
If you're already close to your target, you can search any Web page using Control-F to home in on a particular word or phrase. This command works in Firefox, Internet Explorer, Chrome, Safari, and most other browsers.
Search NIAID, NIH, and Beyond
If what you seek is NIAID-specific, you have two options:
For NIH, you have several options.
To cast an even wider net, try Google or the Google Advanced Search.
Whichever search you use, there's no need to skim the search results page. Use Control-F to quickly check for the words you're looking for.
Use Advanced Search Commands
Google's advanced search commands will help you refine your searches. They work for most NIAID and NIH search fields.
Here's a summary of the top three options from Google's More Search Help:
A word to the wise: think twice before withdrawing your application after peer review. At this point, your application counts as an official submission and there's virtually no advantage to withdrawing.
Worse, pulling the plug at that point has serious repercussions, so you don't want to make a hasty decision.
For an initial application, the consequences are different depending on whether you withdraw before or after getting your summary statement.
For a resubmission, you'll relinquish any chance of funding. And, since you can't resubmit again, you'll have to write an entirely new application. Instead of withdrawing, wait to see how your reviewers evaluate your application. If you don't get a fundable score, their comments may help you create a stronger application the next time around.
Before doing anything—whether contemplating withdrawing or how to proceed after receiving review results—get input and advice from your program officer.
Feel free to send us a question at email@example.com. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
"If a trainee's mentor resigns, can the trainee move to another participating lab or mentor at the current institute and remain on the training grant?"—Suzanne Chapman, Trudeau Institute
Yes. You don't need our permission to make the switch, but you should note the change in the progress report.
"Can I apply for an R21 with one or more Specific Aims from an unfunded R01 application?"—Parmjeet Randhawa, UPMC Montefiore
You may reuse any parts of your R01 application as long as it meets the requirements of the R21 activity code. For more on revising your application, see these resources:
See these and older announcements at NIAID Funding Opportunities List.
back to top
Last Updated November 03, 2011
Last Reviewed August 17, 2011